Tevogen Bio Holdings (FRA:G28) Total Current Assets : €2.26 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Tevogen Bio Holdings's total current assets for the quarter that ended in Dec. 2024 was €2.26 Mil.

Tevogen Bio Holdings Total Current Assets Historical Data

The historical data trend for Tevogen Bio Holdings's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings Total Current Assets Chart

Tevogen Bio Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Total Current Assets

6.35

0.26

1.58

2.26

Tevogen Bio Holdings Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Current Assets	Get a 7-Day Free Trial					1.58	2.21	2.27	3.18	2.26

Tevogen Bio Holdings Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Tevogen Bio Holdings's Total Current Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1.225	+	0.152	+	0	+	0.878
	=	2.26

Tevogen Bio Holdings's Total Current Assets for the quarter that ended in Dec. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1.225	+	0.152	+	0	+	0.878
	=	2.26

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Tevogen Bio Holdings (FRA:G28) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Tevogen Bio Holdings's Liquidation Value for the quarter that ended in Dec. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.225	-	9.68	+	0.75 * 0	+	0.5 * 0
=	-8.46

Tevogen Bio Holdings Total Current Assets Related Terms

Thank you for viewing the detailed overview of Tevogen Bio Holdings's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Tevogen Bio Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (FRA:G28) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

TVGN:USA G28:Germany

Address

15 Independence Boulevard, Warren, NJ, USA, 07059

Website

https://www.tevogen.com

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Tevogen Bio Holdings Headlines

No Headlines